Letter: Aids still kills
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.While acknowledging the tremendous benefit that the new protease inhibitor drugs have brought to many, it is important to realise how far we still are from a cure for Aids ("When plagues end", Review, 16 February).
Similar claims were made when AZT (the first effective drug for Aids) became available in the 1980s, only to be followed by disappointment when it was realised many were unable to take the drug, and that, for those for whom it was effective, the benefits wore off after little more than a year.
The new drugs have only been available for a few months and there are already many accounts of people for whom the side-effects are unbearable, as well as the first reports emerging of people developing resistance to them. Medical research must continue as well as education, for education is the only effective "vaccine" for Aids.
Annabel Kanabus
Aids Education and
Research Trust
Horsham, West Sussex
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments